6683-81-4

Basic information

• Product Name: 2-TERT-BUTYL-4-NITROPHENOL
• Synonyms: 2-TERT-BUTYL-4-NITROPHENOL
• CAS NO: 6683-81-4
• Molecular Formula: C₁₀H₁₃NO₃
• Molecular Weight: 195.22
• Mol File: 6683-81-4.mol
• Article Data: 5

Chemical Properties

• Melting Point: 138.5-139.5 °C
• Boiling Point: 296.4±28.0 °C(Predicted)
• Appearance: /
• Density: 1.173±0.06 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
• PKA: 8.56±0.22(Predicted)
• CAS DataBase Reference: 2-TERT-BUTYL-4-NITROPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-TERT-BUTYL-4-NITROPHENOL(6683-81-4)
• EPA Substance Registry System: 2-TERT-BUTYL-4-NITROPHENOL(6683-81-4)

Safety Data

• Hazardous Substances Data: 6683-81-4(Hazardous Substances Data)

Usage

General Description

2-TERT-BUTYL-4-NITROPHENOL is a chemical compound with the molecular formula C10H13NO3. It is a yellow crystalline solid with a slight, characteristic odor. 2-TERT-BUTYL-4-NITROPHENOL is commonly used as an intermediate in the production of various chemicals, including rubber antioxidants, pesticides, and pharmaceuticals. 2-TERT-BUTYL-4-NITROPHENOL is also used as a polymerization inhibitor and a stabilizer for oils and fuels. It is important to handle this compound with caution, as it is toxic if swallowed, inhaled, or absorbed through the skin, and can cause irritation to the eyes and skin. Additionally, it is harmful to aquatic life and should be handled and disposed of properly according to regulations.

Upstream product

• 100-02-7 4-nitro-phenol 
• 115-11-7 isobutene 
• 88-18-6 2-tert-Butylphenol 
• 6683-78-9 N-(2-tert-butyl-phenyl)-4-methyl-benzenesulfonamide 
• 6683-80-3 1-bromo-2-tert-butyl-4-nitro-benzene 
• 59255-98-0 2-(tert-butyl)-4-nitroaniline 
• 6683-79-0 1-tert-Butyl-5-nitro-2-tosylamino-benzol 

Downstream Products

• 158583-68-7 2-t-butyl-4-nitro-6-(piperidin-1'-ylmethyl)phenol 
• 20294-59-1 2-bromo-6-tert-butyl-4-nitrophenol 
• 1132940-43-2 1-tert-butyl-3-iodo-2-methoxy-5-nitrobenzene 
• 1132937-45-1 N-(4-((3-(tert-butyl)-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxyphenyl)ethynyl)phenyl)methanesulfonamide 
• 1132940-49-8 1-(3-tert-butyl-5-iodo-4-methoxyphenyl )dihydropyrimidine-2,4(1H,3H)-dione 
• 1132940-45-4 3-tert-butyl-5-iodo-4-methoxyaniline 
• 1132941-79-7 1-(3-(tert-butyl)-4-hydroxyphenyl)dihydropyrimidine-2,4(1H,3H)-dione 
• 35292-03-6 3-(tert-butyl)-4-methoxyaniline 
• 15353-20-5 2-tert.-Butyl-4-nitro-anisol 
• 1570188-89-4 (2-tert-butyl-4-nitro-6-{[(2'-dimethylaminoethyl)-methylamino]methyl}phenol-H)ZnSiOPh₃ 
• 1570188-74-7 2-tert-butyl-4-nitro-6-{[(2'-dimethylaminoethyl)methylamino]methyl}phenol 
• 158583-73-4 4-amino-2-t-butyl-6-(piperidin-1'-ylmethyl)phenol 
• 32750-26-8 2-(tert-butyl)-6-iodo-4-nitrophenol 

Relevant articles and documents

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

ABT-072 is a non-nucleoside HCV NS5B polymerase inhibitor that was discovered as part of a program to identify new direct-acting antivirals (DAAs) for the treatment of HCV infection. This compound was identified during a medicinal chemistry effort to impr

URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C

Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2-ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4-dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-phenyl)naphthalen-2-yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-methoxy-styryl- phenyl)methanesulfonamide.

N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS

This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such interm